Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-07

Clinical Trial Update: Dendritic Cells-Derived Exosomes in Human Sepsis

View source ↗

Summary

A clinical trial is evaluating dendritic cell–derived exosomes as a treatment for human sepsis, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dendritic cells-derived exosomes

Snippet

Sponsor: Jinling Hospital, China | Conditions: Sepsis | Status: UNKNOWN